Literature DB >> 29322821

Moderately hypofractionated prostate external-beam radiotherapy: an emerging standard.

Jarad M Martin1, Stephane Supiot2, Paul J Keall3, Charles N Catton4.   

Abstract

Research over recent years has demonstrated that curative external-beam radiotherapy can be safely and efficaciously delivered with roughly half the number of treatments which was previously considered standard. We review the data supporting this change in practice, methods for implementation, as well as emerging future directions.

Mesh：

Year:  2018        PMID： 29322821      PMCID： PMC6223284          DOI： 10.1259/bjr.20170807

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


  49 in total

1.  Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External Beam Radiation Therapy With External Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate.

Authors:  Ian S Dayes; Sameer Parpia; Jaclyn Gilbert; Jim A Julian; Ian R Davis; Mark N Levine; Jinka Sathya
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-05-17       Impact factor: 7.038

2.  Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer.

Authors:  Charles N Catton; Himu Lukka; Chu-Shu Gu; Jarad M Martin; Stéphane Supiot; Peter W M Chung; Glenn S Bauman; Jean-Paul Bahary; Shahida Ahmed; Patrick Cheung; Keen Hun Tai; Jackson S Wu; Matthew B Parliament; Theodoros Tsakiridis; Tom B Corbett; Colin Tang; Ian S Dayes; Padraig Warde; Tim K Craig; Jim A Julian; Mark N Levine
Journal:  J Clin Oncol       Date:  2017-03-15       Impact factor: 44.544

3.  Moderate Hypofractionation in High-Risk, Organ-Confined Prostate Cancer: Final Results of a Phase III Randomized Trial.

Authors:  Giorgio Arcangeli; Biancamaria Saracino; Stefano Arcangeli; Sara Gomellini; Maria Grazia Petrongari; Giuseppe Sanguineti; Lidia Strigari
Journal:  J Clin Oncol       Date:  2017-03-29       Impact factor: 44.544

4.  Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer.

Authors:  Timothy Whelan; Robert MacKenzie; Jim Julian; Mark Levine; Wendy Shelley; Laval Grimard; Barbara Lada; Himu Lukka; Francisco Perera; Anthony Fyles; Ethan Laukkanen; Sunil Gulavita; Veronique Benk; Barbara Szechtman
Journal:  J Natl Cancer Inst       Date:  2002-08-07       Impact factor: 13.506

5.  Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.

Authors:  Alan Pollack; Gail Walker; Eric M Horwitz; Robert Price; Steven Feigenberg; Andre A Konski; Radka Stoyanova; Benjamin Movsas; Richard E Greenberg; Robert G Uzzo; Charlie Ma; Mark K Buyyounouski
Journal:  J Clin Oncol       Date:  2013-10-07       Impact factor: 44.544

6.  Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial.

Authors:  Luca Incrocci; Ruud C Wortel; Wendimagegn Ghidey Alemayehu; Shafak Aluwini; Erik Schimmel; Stijn Krol; Peter-Paul van der Toorn; Hanja de Jager; Wilma Heemsbergen; Ben Heijmen; Floris Pos
Journal:  Lancet Oncol       Date:  2016-06-20       Impact factor: 41.316

7.  Automatic Substitute Computed Tomography Generation and Contouring for Magnetic Resonance Imaging (MRI)-Alone External Beam Radiation Therapy From Standard MRI Sequences.

Authors:  Jason A Dowling; Jidi Sun; Peter Pichler; David Rivest-Hénault; Soumya Ghose; Haylea Richardson; Chris Wratten; Jarad Martin; Jameen Arm; Leah Best; Shekhar S Chandra; Jurgen Fripp; Frederick W Menk; Peter B Greer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-09-05       Impact factor: 7.038

8.  Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience.

Authors:  Patrick A Kupelian; Twyla R Willoughby; Chandana A Reddy; Eric A Klein; Arul Mahadevan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-06-04       Impact factor: 7.038

9.  Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial.

Authors:  David P Dearnaley; Gordana Jovic; Isabel Syndikus; Vincent Khoo; Richard A Cowan; John D Graham; Edwin G Aird; David Bottomley; Robert A Huddart; Chakiath C Jose; John H L Matthews; Jeremy L Millar; Claire Murphy; J Martin Russell; Christopher D Scrase; Mahesh K B Parmar; Matthew R Sydes
Journal:  Lancet Oncol       Date:  2014-02-26       Impact factor: 41.316

10.  Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.

Authors:  David Dearnaley; Isabel Syndikus; Helen Mossop; Vincent Khoo; Alison Birtle; David Bloomfield; John Graham; Peter Kirkbride; John Logue; Zafar Malik; Julian Money-Kyrle; Joe M O'Sullivan; Miguel Panades; Chris Parker; Helen Patterson; Christopher Scrase; John Staffurth; Andrew Stockdale; Jean Tremlett; Margaret Bidmead; Helen Mayles; Olivia Naismith; Chris South; Annie Gao; Clare Cruickshank; Shama Hassan; Julia Pugh; Clare Griffin; Emma Hall
Journal:  Lancet Oncol       Date:  2016-06-20       Impact factor: 41.316
View more
  3 in total

1.  Reduced motion and improved rectal dosimetry through endorectal immobilization for prostate stereotactic body radiotherapy.

Authors:  Jeremiah de Leon; Michael G Jameson; David Rivest-Henault; Sarah Keats; Robba Rai; Sankar Arumugam; Lee Wilton; Diana Ngo; Gary Liney; Daniel Moses; Jason Dowling; Jarad Martin; Mark Sidhom
Journal:  Br J Radiol       Date:  2019-04-24       Impact factor: 3.039

2.  TROG 18.01 phase III randomised clinical trial of the Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation: NINJA study protocol.

Authors:  Jarad Martin; Paul Keall; Shankar Siva; Peter Greer; David Christie; Kevin Moore; Jason Dowling; David Pryor; Peter Chong; Nicholas McLeod; Avi Raman; James Lynam; Joanne Smart; Christopher Oldmeadow; Colin I Tang; Declan G Murphy; Jeremy Millar; Keen Hun Tai; Lois Holloway; Penny Reeves; Amy Hayden; Tee Lim; Tanya Holt; Mark Sidhom
Journal:  BMJ Open       Date:  2019-08-20       Impact factor: 2.692

3.  Absence of correlation between radiation-induced CD8 T-lymphocyte apoptosis and sequelae in patients with prostate cancer accidentally overexposed to radiation.

Authors:  Guillaume Vogin; Jean-Louis Merlin; Alexandra Rousseau; Didier Peiffert; Alexandre Harlé; Marie Husson; Labib El Hajj; Mihai Levitchi; Tabassome Simon; Jean-Marc Simon
Journal:  Oncotarget       Date:  2018-08-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.